Allogeneic peripheral blood stem cell (PBSC) transplant has recently been introduced for the treatment of hematological malignancies. As the data were limited mainly to adult patients, this study aimed to assess the feasibility and safety of this procedure in pediatric patients and donors. Eleven ch
Murine allogeneic in vivo stem cell homing,
✍ Scribed by Gerald A. Colvin; Jean-Francois Lambert; Mark S. Dooner; Jan Cerny; Peter J. Quesenberry
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 220 KB
- Volume
- 211
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Stem cell homing has been studied in syngeneic models and appears to be rapid (<1 h) and dependent on cellular adhesion and migration factors. We utilized a full H2‐mismatched transplantation model to determine the basics of allogeneic homing. C57BL/6J Lin‐Sca‐1+ cells were labeled with CFSE and injected in non‐myeloablated BALB/c mice. Fluorescent cell detection was via high‐speed FACS analysis. Alternatively, B6.SJL whole bone marrow cells were injected in lethally irradiated BALB/c mice (10 Gy). One, 3, 6, and 24 h after transplant, marrow was harvested and cells were either plated for high proliferative potential colony‐forming cell (HPP‐CFC) assay or secondarily injected into myeloablated (8 Gy) C57BL/6J mice using 10% competing C57BL/6J marrow. Chimerism was evaluated at 8 weeks. CFSE+ cells were detected in the bone marrow 1, 3, and 6 h after injection. The numbers were moderately lower when compared to syngeneic homing possibly due to strain effect. Conversely, utilizing a surrogate or secondary assay, we observed a decline of secondary engraftment of harvested cells over time, but not of HPP‐CFC. Combining experiments and normalizing the 1‐h time point to 100% (to allow comparison), we observed a mean relative engraftment of 87 ± 29%, 72 ± 21%, 84 ± 35% of the 1 h level at 3, 6, and 24 h respectively. HPP‐CFC assay showed no significant variation as a homing surrogate over 1–6 h. These data indicate a rapid homing into allogeneic recipients with a plateau at 1 h. The decline of secondary engraftability over time may indicate a phenotype alteration of homed cells. J. Cell. Physiol. 211: 386–391, 2007. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Allogeneic haemopoietic stem cell transplantation is curative for many patients with haematologic disorders. Despite advances in supportive care, complications such as graft‐versus‐host disease (GVHD) and infection remain important causes of morbidity and mortality after transplantation
Unmodified allogeneic peripheral blood stem cell transplantation (alloPBSCT) was performed in 20 consecutive acute non-lymphoblastic leukemia (ANLL) patients from their HLA-identical siblings. There were 11 males and 9 females. Median age was 34 years (range 17-43). Donors were primed with 2•5-15 g/
## Abstract Although preliminary results suggest that allogeneic hematopoietic stem cell transplantation (allo HCT) for ovarian cancer (OC) is a feasible procedure, the low patient number in previous studies had limited ability to evaluate the true benefit of allo HCT in OC. This retrospective mult